DIN 02467992 — NAT-BOSENTAN 125 MG
NAT-BOSENTAN is a tablet of Bosentan marketed by NATCO PHARMA (CANADA) INC. The full Bosentan monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02467992
- Brand name
- NAT-BOSENTAN
- Active ingredient
- Bosentan
- Strength
- 125 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- NATCO PHARMA (CANADA) INC
- Health Canada status
- DORMANT
- Drug class
- Endothelin receptor antagonist
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Bosentan products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02399210 | APO-BOSENTAN | 125 MG | TABLET | APOTEX INC | DORMANT |
| 02399202 | APO-BOSENTAN | 62.5 MG | TABLET | APOTEX INC | DORMANT |
| 02467984 | NAT-BOSENTAN | 62.5 MG | TABLET | NATCO PHARMA (CANADA) INC | DORMANT |
| 02383020 | PMS-BOSENTAN | 125 MG | TABLET | PHARMASCIENCE INC | MARKETED |
| 02383012 | PMS-BOSENTAN | 62.5 MG | TABLET | PHARMASCIENCE INC | MARKETED |
| 02483149 | TARO-BOSENTAN | 125 MG | TABLET | TARO PHARMACEUTICALS INC | MARKETED |
| 02483130 | TARO-BOSENTAN | 62.5 MG | TABLET | TARO PHARMACEUTICALS INC | MARKETED |
| 02244982 | TRACLEER | 125 MG | TABLET | JANSSEN INC | MARKETED |
| 02244981 | TRACLEER | 62.5 MG | TABLET | JANSSEN INC | MARKETED |